{"podcast":{"title":"Neurology® Podcast","slug":"neurology-podcast-635512","podcast_index_feed_id":635512,"rss_url":"https://neurology.libsyn.com/rss","website_url":"https://www.neurology.org/podcast","image_url":"https://static.libsyn.com/p/assets/6/9/3/4/6934e698efec7fdd/NJpodcast_1400x1400.png","author":"Sharon Quimby","episode_count":1373,"summary":"The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.","last_synced_at":"2026-08-02T04:20:23.930610+00:00","page_url":"https://stenobird.com/podcast/neurology-podcast-635512"},"episode":{"title":"Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2","slug":"updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-2","published_at":"2026-07-30T16:00:00+00:00","page_url":"https://stenobird.com/podcast/neurology-podcast-635512/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-2","show_page_url":"https://stenobird.com/podcast/neurology-podcast-635512","url":"https://neurology.libsyn.com/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-2","audio_url":"https://traffic.libsyn.com/secure/neurology/Neurology_Podcast_-_July_30th_2026_v2.mp3?dest-id=937793","summary":"In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting . Read more about the Fenebrutinib Trial . Disclosures can be found at Neurology.org .","meta_description":"In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safe…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1227,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neurology-podcast-635512/episodes/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-2/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neurology-podcast-635512/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-2.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}